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Abstract
Testicular adrenal rest tumours (TARTs) are benign adrenal-like testicular tumours that 
frequently occur in male patients with congenital adrenal hyperplasia. Recently, GATA 
transcription factors have been linked to the development of TARTs in mice. The aim of 
our study was to determine GATA expression in human TARTs and other steroidogenic 
tissues. We determined GATA expression in TARTs (n = 16), Leydig cell tumours (LCTs; 
n = 7), adrenal (foetal (n = 6) + adult (n = 10)) and testis (foetal (n = 13) + adult (n = 8)). We 
found testis-like GATA4, and adrenal-like GATA3 and GATA6 gene expressions by qPCR in 
human TARTs, indicating mixed testicular and adrenal characteristics of TARTs. Currently, 
no marker is available to discriminate TARTs from LCTs, leading to misdiagnosis and 
incorrect treatment. GATA3 and GATA6 mRNAs exhibited excellent discriminative power 
(area under the curve of 0.908 and 0.816, respectively), while immunohistochemistry 
did not. GATA genes contain several CREB-binding sites and incubation with 0.1 mM 
dibutyryl cAMP for 4 h stimulated GATA3, GATA4 and GATA6 expressions in a human 
foetal testis cell line (hs181.tes). Incubation of adrenocortical cells (H295RA) with ACTH, 
however, did not induce GATA expression in vitro. Although ACTH did not dysregulate 
GATA expression in the only human ACTH-sensitive in vitro model available, our results 
do suggest that aberrant expression of GATA transcription factors in human TARTs might 
be involved in TART formation.
Introduction
Congenital adrenal hyperplasia (CAH) is a genetic disorder 
in which adrenocortical steroid synthesis is impaired due 
to a deficiency in particular steroidogenic enzymes, most 
often steroid 21-hydroxylase (CYP21A2). A wide range of 
the male CAH patients from 12.5% up to 94% are reported 
to develop testicular adrenal rest tumours (TARTs), 
which are an important cause of infertility (1, 2). TARTs 
are benign tumours with steroidogenic characteristics, 
located near the mediastinum testis (1, 3). Until now, the 
aetiology and origin of TARTs have remained uncertain. 
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TARTs were originally thought to arise from adrenal rest 
cells, based on the presence of adrenal characteristics, 
such as expression of adrenal enzymes and receptors 
(4, 5). However, recently we also described testicular 
characteristics of TARTs (6). This has shifted the hypothesis 
toward a more pluripotent steroidogenic cell type as the 
origin of TARTs (6), possibly from cells originating in the 
urogenital ridge or adrenogonadal primordium.
Besides exhibiting both adrenal and testicular 
characteristics, TARTs also share morphological 
similarities with steroid-producing testicular Leydig cells. 
As a consequence, it is difficult to discriminate TARTs 
from Leydig cell tumours (LCTs). Both TARTs and LCTs 
are rare tumours (7). Although rare entities, several cases 
of LCTs in CAH patients have been described (8, 9, 10, 
11, 12, 13). Discrimination between LCTs and TARTs is 
important as these require different treatment strategies. 
TARTs are detected using ultrasound or MRI investigation. 
Currently, TARTs will only be surgically removed from the 
testis when pain complaints are present (3), while LCTs 
will be surgically removed using a testis-sparing procedure 
or total orchiectomy (7). No single marker is available yet 
to accurately discriminate TARTs from LCTs, increasing 
the chance of misdiagnosis and consequently incorrect 
treatment, of which at least 2 cases have been reported in 
literature (14, 15).
GATA transcription factors are involved in 
development (by regulating cell fate specification) and 
differentiation in all eukaryotic organisms. These factors 
are able to bind to a consensus DNA element, WGATAR, 
known as the GATA motif (16, 17). Historically, GATA 
transcription factors are divided into two families: GATA1, 
GATA2 and GATA3 are classified as haematopoietic 
factors, while GATA4, GATA5 and GATA6 are classified as 
endodermal factors. Their expression is also described in 
almost all foetal and adult tissues, and they are involved in 
adrenogonadal development. Three GATA factors (GATA 
1, 4, 6) are expressed in the somatic cell population of the 
testis, while GATA3 is expressed in the adrenal medulla 
(reviewed in Viger and coworkers 18).
A possible relation between the expression of GATA 
transcription factors during adrenogonadal development 
and TART development was proposed in commentaries in 
the study of Padua and coworkers (19) by Heikinheimo 
and coworkers (20) and Pihlajoki (21). Padua and 
coworkers (19) developed a mouse model lacking both 
GATA4 and GATA6 expressions in steroidogenic cells. 
These mice suffer from adrenal aplasia, and female mice 
die within days after birth. However, male mice survive 
because of corticoid production by adrenal-like cells in 
the testes, which Heikinheimo (20) and Pihlajoki (21) 
proposed might be similar to TART cells. Interestingly, 
GATA genes contain cAMP response element-binding 
protein (CREB) sites, and cAMP induces expressions of 
GATA4 and GATA6 in gonadal cell lines (22, 23, 24). Levels 
of ACTH, the receptor of which signals via cAMP, are 
raised in CAH patients, due to lack of negative feedback 
on the Hypothalamic–Pituitary–Adrenal axis, caused by 
low or absent cortisol levels due to the adrenal enzyme 
deficiency. Furthermore, ACTH levels are associated 
with the occurrence of TARTs (25, 26, 27). Therefore, we 
hypothesized that dysregulation of GATA transcription 
factors by increased ACTH levels in utero might be involved 
in the aetiology of TARTs.
The aim of our study was therefore to determine 
the expression of GATA transcription factors in TARTs 
and other steroidogenic tissues. We determined their 
discriminative potential to discern TARTs from LCTs, and 
studied the role of cAMP and ACTH in the aetiology of 
TARTs in vitro.
Methods
GATA expression analysis in human material
Tissues and patients Sixteen TART samples from 
8 adult CAH patients (tumour left and right testis) 
were previously collected as described by Claahsen 
and coworkers (3, 5) (informed consent was obtained). 
Paraffin-embedded material for immunohistochemistry 
was available for all tumours, while frozen material for 
RNA isolation was available for 12 samples. Additionally, 
2 frozen histologically proven TART samples from one 
anonymous CAH patient were obtained. Frozen material 
of normal testis (n = 8), normal adrenal (n = 10) and benign 
LCT (n = 7) was obtained. Furthermore, paraffin-embedded 
material was available for 4 benign LCTs and 3 metastases 
of malignant LCTs. These coded (identifiable anonymous) 
testis tissues, adrenal tissues, benign LCTs, metastases of 
malignant LCTs and TART samples were obtained from 
the Pathology and Urology departments and used in 
accordance with the Code of Conduct of the Federation 
of Medical Scientific Societies in the Netherlands (http://
www.federa.org/codes-conduct; research approved 
by institutional review board: CMO Radboudumc 
#2016-2977 and CMO-nr 2004/007).
To study the aetiology of TARTs, we also included 
foetal adrenal and testis tissues. Six human foetal adrenals 
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(first and second trimesters) and cDNA from 13 foetal testis 
tissues (second trimester) were obtained from the MRC 
Centre for Reproductive Health, University of Edinburgh. 
Tissues were obtained following elective termination of 
pregnancy and anonymized. Women gave informed 
consent in accordance with national guidelines (42), and 
ethical approval was obtained from the Lothian Research 
Ethics Committee.
RNA isolation Frozen tissue sections (at least 
10 × 20 µm) or cultured cells were used for RNA isolation 
(Total RNA Purification kit, Norgen, Thorold, Canada) 
according to manufacturer’s instructions. Samples were 
treated with DNase (RNase-free DNase set, Qiagen). 
RNA concentrations and purity were determined using a 
NanoDrop 2000 Spectrophotometer.
Reverse transcription and qPCR 0.1 µg (foetal 
testis), 0.2 µg (first-trimester adrenal) or 0.5 µg (second 
trimester adrenal and adult samples) of total RNA was 
used for cDNA synthesis using Superscript II reverse 
transcriptase (Thermo Fisher Scientific), performed 
according to the manufacturer’s protocol with a 2720 
Thermal cycler (Applied Biosystems) in a final volume of 
20 µL. Gene-specific primers of GATA1, GATA3, GATA4 
and GATA6 were self-designed (Supplementary Table  1, 
see section on supplementary data given at the end of this 
article). For qPCR, the cDNA of adult samples was diluted 
5 times, while the cDNA of foetal samples was diluted 
20 times, and 2 µL was added to 7.5 µL IQSYBR Green 
Supermix (Bio-Rad Laboratories), in a total amount of 
15 µL on a CFX96 Touch Real-Time PCR Detection System 
(Bio-Rad Laboratories). As foetal testis cDNA was not 
DNase-treated, a non-RT control was used to determine 
genomic DNA contamination.
Immunohistochemistry GATA3 immunostaining 
was performed using a standardized protocol optimized 
for the localization of GATA3 in urothelial carcinoma 
(antibody L50-823, 1:50 dilution, Biocare Medical/
Klinipath, Duiven, The Netherlands). Kidney sections 
were used as positive control. GATA6 immunostaining 
(sc-9055; 1:200 dilution, SantaCruz Biotechnology) 
was performed manually including negative control 
sections with only primary antibody diluent. All 
sections were visualized with VisionTek (Sakura, 
Tokyo, Japan).
Regulation of GATA transcription factors
Cell culture The Hs181.tes cell line was obtained from 
American Type Culture Collection (ATCC CRL-7131), while 
the H295RA cell line was obtained from the University of 
Michigan (28). Cells were grown as a monolayer culture, 
although the H295RA cells tend to grow in clumps. Media 
for Hs181.tes cells consisted of DMEM with 4.5 g/L glucose 
with l-glutamine (Lonza; Leusden, Netherlands), whilst 
DMEM/F12 (Lonza) was used for H295RA cells. Both media 
were supplemented with 10% foetal bovine serum (Gibco; 
Thermo Fisher Scientific) and 1% antibiotics (penicillin-
streptomycin 10,000 U/mL; Gibco). Cells were cultured 
at 37°C in a humidified 95% air/5% CO2 atmosphere. 
Medium was changed 2–3 times a week and Hs181.tes 
cells were passaged when confluent using 0.25% trypsin 
(BD Diagnostic Systems, Breda, The Netherlands), while 
for H295RA cells, 0.05% trypsin-EDTA (Gibco) was used.
Dibutyryl cAMP and ACTH studies Hs181.tes and 
H295RA cells were washed, harvested and plated (1:6 
dilution) into a 6-well plate (Costar, Corning Life Sciences). 
After 24 h, cells were starved overnight using serum-free 
medium (Hs181.tes) or low-serum experimental medium 
(1% FBS; H295RA). RNA was isolated after cells were 
treated with 0.1 mM dibutyryl cAMP (dbcAMP; Sigma) for 
either 30 min, 4 h or not treated at all. ACTH incubation 
experiments were only performed in the H295RA cells, as 
Hs181.tes cells are insensitive to ACTH. RNA was isolated 
after cells were not treated or treated with 2 or 10 nM 
ACTH (Synacthen, Radboudumc Pharmacy, Nijmegen, 
The Netherlands) for either 30 min, 4 h or 24 h.
Data analysis
Gene expression mRNA expression of all genes was 
calculated using the delta Ct method (2−∆Ct). All values 
were normalized to the corresponding HPRT value (29). 
Data were transferred to GraphPad Prism 5 and IBM SPSS 
22.0 (SPSS Inc.) for further analyses. Differences between 
different tissues and conditions were tested for statistical 
significance with non-parametric tests. To determine 
the diagnostic properties of GATA in discriminating 
TARTs from LCTs, Mann–Whitney U was performed 
and following Receiver Operating Characteristic (ROC) 
analyses were performed. The area under the curve (AUC) 
represents the probability that the outcome correctly 
classifies the tissue as TART or benign LCT (range 0.5 (no 
accuracy) to 1 (prefect accuracy)). To determine the role 
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of GATA in the aetiology of TARTs, a comparison between 
TARTs and testes (foetal and adult), TARTs and adrenals 
(foetal and adult) was made. Furthermore, expressions 
in foetal tissues were compared with each other (adrenal 
vs testis), as well as expressions in adult tissues (adrenal 
vs testis). Also, expressions in foetal and adult testis, and 
foetal and adult adrenal tissues were compared. These 
comparisons were analysed with the Kruskal–Wallis test 
followed by Dunn’s post hoc test. Gene expression analyses 
within cell culture studies were also compared using the 
Kruskal–Wallis test followed by Dunn’s post hoc test. Values 
of P ≤ .05 (*) or P ≤ .01 (**) or P ≤ .001 (***) were considered 
statistically significant.
Protein immunohistochemistry IHC stainings 
for GATA3 and GATA6 in TARTs and LCTs were visually 
examined by two independent investigators (MAMvZ, ME). 
GATA3 and GATA6 were scored based on pseudoquantative 
histoscore: intensity of staining was recorded as negative, 
weak, moderate or strong. Furthermore, an estimation 
of the percentage of positive cells was made. For GATA3, 
only nuclear staining was scored as GATA3 staining is 
already validated for urothelial cell carcinoma, indicating 
only nuclear staining as a positive reaction. In contrast, 
as GATA6 staining is still experimental, we considered 
both nuclear and cytoplasmic stainings as positive. For 
GATA3, nuclear reactivity of the tubular cells of the 
kidney was used as external positive control for the 
staining procedure. For GATA6, tissue sections without 
primary antibody were used as a negative control for the 
staining procedure. Cytoplasmic staining in GATA6 was 
corrected for any lipofuscin present by comparing the 
negative control directly with the GATA6 staining. In 
the cases of staining heterogeneity, the highest level was 
reported. Staining scores were compared between the two 
investigators (MAMvZ, ME) and both agreed on reported 
(consensus) scores.
Results
Adrenal and testicular expression levels of GATA 
transcription factors in TARTs
To test whether expression of GATA1, GATA3, GATA4 and 
GATA6 is a marker of different tissues or disease states, 
qPCR was performed (Fig.  1). Separate analyses were 
performed to determine their discriminative potential 
between TARTs and LCTs (Fig. 1 underlined significance) 
and to determine their role in the aetiology of TARTs 
by comparison with foetal and adult testis and adrenal 
tissues (Fig. 1 non-underlined significance).
Figure 1
Gene expressions of GATA1 (A), GATA3 (B), GATA4 
(C) and GATA6 (D) in human TARTs, adult testes, 
foetal testes, adult adrenals and foetal adrenals. 
mRNA expression was calculated using the delta 
Ct method. All values were normalized to 
corresponding HPRT expression. The symbols in 
the graph represent all samples used and the 
error bars indicate median and 25th and 75th 
percentiles. Significance was tested with the 
Mann–Whitney-U (MWU) test or Kruskal–Wallis 
and Dunn’s post hoc test comparing selected pairs 
of variables. Underlined significances are from 
the biomarker analysis comparing TARTs and LCTs 
(MWU). Non-underlined significances are from 
the aetiology analysis comparing TART, adult 
adrenal, adult testis, foetal adrenal and foetal 
testis tissues. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; 
ct>40 means that mRNA was not detected in 
these samples. LCTs, Leydig cell tumours; TARTs, 
testicular adrenal rest tumours.
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Expression of GATA1 was significantly higher in foetal 
adrenals compared to foetal testes (28.4-fold, P ≤ 0.01) and 
adult adrenals (61.1-fold, P ≤ 0.01) (Fig. 1A).
GATA3 expression was maximal in foetal adrenals, 
which was 190-fold higher compared to foetal testis 
tissues (P ≤ 0.001). GATA3 expression was also significantly 
higher in adult adrenals compared to adult testes 
(73.7-fold, P ≤ 0.001), and expression in TARTs was 
significantly higher compared to foetal (17.8-fold, 
P ≤ 0.05) and adult (26.9-fold, P ≤ 0.01) testes (Fig. 1B).
Gene expression of GATA4 was significantly higher 
(32.4-fold) in TARTs compared to adult adrenals (P ≤ 0.01). 
Significantly higher GATA4 expression (33.5-fold) was 
found in foetal testis tissues compared to foetal adrenal 
tissues (P ≤ 0.001) (Fig. 1C).
GATA6 expression levels were 16.6-fold higher in 
adult adrenals compared to adult testes (P ≤ 0.001), while 
GATA6 expression in TARTs was higher compared to 
foetal (6.3-fold, P ≤ 0.05) and adult (9.3-fold, P ≤ 0.05) 
testes (Fig. 1D).
The results of the gene expression analyses are 
summarized in Fig.  2: GATA3 and GATA6 are highly 
expressed in foetal and adult adrenal tissues, while GATA4 
is highly expressed in foetal and adult testis tissues. 
TARTs express high levels of GATA3, GATA4 and GATA6, 
indicating adrenal- and testis-like expression patterns of 
GATA transcription factors.
GATA3 and GATA6 mRNA levels can discriminate 
TARTs from LCTs, while protein levels cannot
Next, we compared GATA expression and their 
discriminative potential between TART and LCT tissues, 
as there is currently no single marker that can distinguish 
between these two pathologies. GATA3 gene expression 
was 15.8-fold higher expressed in TART compared to LCT 
tissues (P ≤ 0.01 Fig. 1B), and GATA6 was 16.5-fold higher 
expressed in TARTs compared to LCTs (P ≤ 0.05 Fig. 1D), 
while GATA4 showed no significant difference between 
TARTs and LCTs (Fig. 1C). To determine the discriminative 
potential in distinguishing TARTs from LCTs based 
on GATA3 or GATA6 gene expression, we performed 
ROC analyses. GATA3 showed excellent discriminative 
potential to differentiate TARTs from LCTs with an AUC of 
0.908, while GATA6 showed good discriminative potential 
with an AUC of 0.816 (Fig. 3).
To enhance the clinical applicability of GATAs as TART 
biomarkers and to determine which cells express GATA, 
we set out to assess GATA3 and GATA6 expressions using 
Figure 2
Gene expression of GATA transcription factors during gonadal and 
adrenal developments. The figure summarizes the results of our gene 
expression analysis in relation to adrenogonadal development. Cells from 
the adrenal primordium combined with neural crest cells give rise to the 
foetal adrenal, which will mature into the adult adrenal. The testis 
develops from the bipotential gonad. In this study, we measured gene 
expression levels of GATA1, GATA3, GATA4 and GATA6 in human TART, 
foetal and adult adrenal, and foetal and adult testis tissues. Of note, we 
are uncertain of cell-specific expression as we measured expression in 
total tissue. GATA3 and GATA6 were expressed in both foetal and adult 
adrenals, while GATA4 was expressed in the foetal as well as the adult 
testes. GATA3, GATA4 and GATA6 gene expressions were all found in 
TARTs. TARTs, testicular adrenal rest tumours. Reproduced from Viger RS, 
Guittot SM, Anttonen M, Wilson DB, Heikinheimo M, Role of the GATA 
family of transcription factors in endocrine development, function, and 
disease, Molecular Endocrinology, 2008, volume 22, issue 4, pages 
781–798, by permission of Oxford University Press. Copyright 2008, The 
Endocrine Society (18).
Figure 3
Discriminative potential of GATA3 and GATA6 gene expressions in 
distinguishing TARTs from LCTs. Receiver operating characteristic analyses 
were performed. An area under the curve of 0.908 was observed for 
GATA3, while this was 0.816 for GATA6. LCTs, Leydig cell tumours; TARTs, 
testicular adrenal rest tumours.
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immunohistochemistry on paraffin-embedded formalin-
fixed tissues. Protein expression was analysed in TARTs 
(n = 16), benign LCTs (n = 4) and metastases of malignant 
LCTs (n = 3). GATA3 protein expression was undetectable 
in all TART samples as well as in all LCTs, while the tubular 
cells of kidney sections (positive control) showed nuclear 
expression (Fig.  4). In TARTs and LCTs, GATA6 protein 
expression was heterogeneous (Supplementary Figs  1 
and 2), while expression was absent in negative control 
samples (Fig. 4). Both nuclear and cytoplasmic stainings 
were observed, with a high variability in intensity and 
percentage of positive cells. TARTs and benign LCTs show 
similar intensity and percentage of cells with GATA6 
protein expression, while protein expression of GATA6 in 
metastases of malignant LCTs is almost absent as there are 
only very few cells with staining (Fig. 4).
GATA transcription factors and their possible role in 
the aetiology of TARTs
We hypothesized that prenatal exposure of foetal 
steroidogenic pluripotent cells to ACTH might induce 
TARTs via GATA transcription factors. ACTH acts on 
the ACTH receptor (MC2R), a G-coupled protein, using 
cAMP as a second messenger. Indeed, one or multiple 
CREB-binding sites occur inside the gene body or up to 
10 kb upstream of the transcription start site of multiple 
GATA genes (http://sabiosciences.com/chipqpcrsearch.
php?app=TFBS), suggesting that cAMP could be a GATA 
expression-inducing second messenger, involved in de- 
and/or upregulation of GATAs in TARTs.
Incubation of a foetal testis cell line (hs181.tes) with 
0.1 mM of dbcAMP for 4 h showed a moderate increase in 
gene expressions of GATA3, GATA4 and GATA6, although 
this did not reach statistical significance (Fig.  5A). 
However, there is no in vitro model of foetal testis cells 
expressing MC2R. Therefore, we used an ACTH-sensitive 
adrenocortical cell line (H295RA).
ACTH incubation with 2 nM (results not shown) or 
10 nM (Fig. 5B) for 30 min, 4 h or 24 h increased MC2R and 
CYP11B1 gene expressions (positive controls), indicating 
that the system is indeed responsive to ACTH. However, 
no altered gene expressions for GATA3, GATA4 or GATA6 
were found.
Figure 4
GATA3 and GATA6 protein expressions in human TARTs, benign LCTs, metastases of malignant LCTs and control tissues. GATA3 and GATA6 expressions 
(positive staining) are indicated by brown nuclei and/or brown cytoplasm. Protein expression of GATA3 is present in the positive control tissue (kidney), 
but absent in TARTs, benign LCTs and metastases of malignant LCTs. Protein expression of GATA6 is present in the cytoplasm and nuclei of TARTs and 
benign LCTs, however absent in metastases of malignant LCTs and the negative control (tissue slides without primary antibody). Representative pictures 
are shown. Scale bar represents a distance of 50 µm. LCTs, Leydig cell tumours; TARTs, testicular adrenal rest tumours.
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Discussion
To the best of our knowledge, this is the first description 
of GATA transcription factors in human TARTs. TARTs 
expressed both testicular (GATA4) and adrenal (GATA3 
and GATA6) characteristics, thereby confirming our 
previous findings of both adrenal and testicular features 
of TARTs (6). Furthermore, differences in GATA3 and 
GATA6 mRNA expression levels might be used to 
discriminate TARTs (high) from LCTs (low expression), 
indicated by good AUCs (>0.8) in ROC analyses, although 
at the protein expression level, immunohistochemistry 
did not discriminate. In addition, as long-term exposure 
to elevated ACTH levels is linked to occurrence of TART 
(25, 26, 27), we hypothesized that (prenatal) exposure 
of (primordial) steroidogenic cells in the testes to 
ACTH might induce TARTs via deregulation of GATA 
transcription factors. Human foetal testis cells indeed 
show increased GATA expression after incubation with 
cAMP. However, adrenocortical cells (the only human 
ACTH-sensitive model available) did not show increased 
expression after ACTH incubation.
Although interesting to again find both adrenal- and 
testis-like characteristics of TARTs, this expression pattern 
does not correspond to the expression pattern observed 
in the adrenal-like cells of the GATA4/GATA6 double-
knockout mice described earlier (19). The steroidogenic 
cells in the double-knockout mice should not express 
GATA4 and GATA6, as the model eliminated expression 
in all steroidogenic cells. In addition, the adrenal-like cells 
in these mice lacked HSD17B3 and INSL3 expressions, 
whereas these genes are expressed in human TARTs (19). 
Therefore, the observed gene expression patterns of 
adrenal-like cells found in these mice do not resemble the 
observed gene expression pattern of human TART.
We assessed the potential of GATA transcription 
factors as differential diagnostic tools to discriminate 
TARTs from LCTs, which are difficult to distinguish 
due to their morphological resemblance. Misdiagnosis 
can have profound consequences for the treatment of 
a patient with a testicular tumour (8, 11). Therefore, 
a clinical need for differential diagnostic markers that 
can differentiate between both pathologies exists. 
Bilateralism of the tumours (25, 30), presence of Reinke 
crystals (1, 5, 25, 31, 31, 32, 33, 34) and expressions 
of synaptophysin, Inhibin α, CD56, androgen receptor, 
DLK1, INSL3, CYP11B1, CYP21A2 and MC2R (33, 34, 
35, 36) have all been studied as potential markers, 
but none of these markers individually can reliably 
discriminate TARTs from LCTs. We found significantly 
higher gene expressions of GATA3 and GATA6 in 
TARTs compared to LCTs with good discriminative 
potential. This suggests that measurement of these 
genes may be used in a diagnostic setting as a 
discriminative marker between TART and LCT tissues. 
To improve the usefulness of these markers in the 
Figure 5
GATA transcription factors and their possible role in the aetiology of TARTs. Long-term exposure to elevated levels of ACTH is present in patients with 
congenital adrenal hyperplasia and this is associated with the development of TARTs. ACTH binds to its receptor (MC2R), using cAMP as a second 
messenger. CREB-binding sites are present within the gene body or up to 10 kb upstream of the transcription start site in GATA3, GATA4 and GATA6. 
cAMP could therefore be a GATA expression-inducing second messenger. Source: http://sabiosciences.com/chipqpcrsearch.php?app=TFBS. (A) Hs181.tes 
cells were incubated with 0.1 mM dibutyryl cAMP (Hs181.tes cells do not express ACTH receptor) for 0 min, 30 min or 4 h. Gene expression was calculated 
using the delta Ct method and corresponding HPRT expression was used to normalize. (B) H295RA cells were incubated with 10 nM ACTH for 0 min, 
30 min, 4 h or 24 h. Delta Ct method and corresponding HPRT value were used to calculate normalized gene expression.
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clinic and to determine which cells express GATA, 
we determined protein expressions of GATA3 and GATA6 
on paraffin-embedded tumour samples using standard 
immunohistochemical techniques. GATA3 protein 
expression, however, was undetectable in TARTs and 
LCTs. On the other hand, GATA6 protein expression was 
heterogeneous both within and between TART, benign 
LCT and metastases of malignant LCT tissue samples. 
We observed high variability in the location, intensity 
of staining and percentage of GATA6-positive cells. We 
identified very low expression of GATA6 in metastases 
of malignant LCTs, which might reflect a change in the 
status in the primary tumour cells promoting invasion. 
Nevertheless, GATA6 expression is heterogeneously 
expressed within and between TARTs and benign LCTs, 
and it can therefore not be used as a discriminatory 
biomarker for these pathologies.
We also determined GATA expression in human 
foetal adrenal and testis tissues. GATA1 was the only 
GATA gene in which a significant change in expression 
was identified between foetal and adult adrenal tissues. 
We found GATA4 expression in foetal and adult testis 
tissues, and GATA6 expression in foetal and adult adrenal. 
Previous findings are in agreement with our data. Viger 
and coworkers summarized all known literature on GATA 
expression in adrenogonadal development, mainly based 
on mice models (18). However, as we studied human 
TARTs, we will focus on reported expression in human 
tissues. Ketola and coworkers found GATA4 and GATA6 
mRNAs and protein expressions in human foetal testis 
tissues, although a decreasing trend with advanced foetal 
development was observed for GATA6 expression (37). 
In foetal testis tissues, GATA4 was the predominantly 
expressed GATA gene. Jiminez and coworkers found 
GATA6 expression in human adult adrenal tissues, but 
no GATA4 expression (38). This is in agreement with 
Kiiverii and coworkers who showed GATA4 and GATA6 
expressions in human foetal adrenal, but only GATA6 
mRNA and protein expression in human adult adrenal 
(39). In summary, and in correspondence with known 
literature, we found expression of GATA4 in foetal and 
adult testis tissues, and GATA6 expression in foetal and 
adult adrenal tissues. In addition, we found GATA3 
expression in foetal and adult adrenal tissues.
We found high relative gene expression levels of 
GATA3, GATA4 and GATA6 in TARTs, suggesting that 
dysregulation of these transcription factors is involved 
in the aetiology of TARTs. GATA genes contain one or 
several CREB sites and previously cAMP was described to 
induce GATA4 and GATA6 expressions in the gonadal cell 
lines MSC-1, mLT and MA-10 (22, 23, 24). We therefore 
stimulated foetal testis cells with cAMP and indeed 
found moderate increase in expressions of GATA3, 4 
and 6. The ACTH receptor (MC2R) signals via cAMP and 
elevated ACTH levels are present in CAH patients and 
associated with the development of TARTs (25, 26, 27). 
We hypothesized that dysregulation of GATA expression 
by ACTH in foetal steroidogenic cells could eventually 
lead to the formation of TARTs. Regretfully, no human 
foetal cell lines are available that express functional 
MC2R. Human cell lines, in general, tend to have low 
(functional) ACTH receptor expression, although several 
adrenocortical cell lines, including H295R cells, are 
known to have at least moderate expression of MC2R (40, 
41). ACTH responsiveness in H295R cells was increased 
by over-expression of MRAP, resulting in the H295RA 
cell line, the only human ACTH-sensitive cell line 
available (28). We are aware of the limitation of using a 
differentiated cell line as a model for the involvement of 
ACTH in foetal steroidogenic cells. In the present study, 
we demonstrated that ACTH does not influence GATA 
expression in H295RA cells. Timing of ACTH exposure 
might play an important role in GATA dysregulation. 
Therefore, dysregulation of GATA might still be a key 
player in the formation of TART and is possibly regulated 
by ACTH prenatally.
In conclusion, testis-like expression of GATA4 and 
adrenal-like expressions of GATA3 and GATA6 were 
observed in TARTs, suggesting that dysregulation of GATA 
transcription factors in a pluripotent foetal cell is involved 
in TART formation. Furthermore, gene expression of 
GATA transcription factors showed good discriminative 
potential to differentiate TARTs from LCTs, but further 
studies have to be performed establishing thresholds 
in less-invasive material such as blood or urine to be of 
applicable use.
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